Urges Congress to deschedule marijuana as Schedule 1 controlled substance under federal "Controlled Substances Act."
The resolution aims to alleviate restrictions that currently hinder medical marijuana patients from accessing insurance coverage for cannabis treatment. It acknowledges that there are approximately 5.4 million individuals in the U.S. who are eligible medical marijuana patients but are unable to benefit from insurance for cannabis-related treatments because of its Schedule I designation. Furthermore, with the federal classification, dispensaries face extensive legal risks, impact their safety and security, leading to increased cash burdens and exposure to theft.
Assembly Resolution No. 153 (AR153) urges the United States Congress to deschedule marijuana as a Schedule I controlled substance under the federal 'Controlled Substances Act'. The resolution highlights that the current classification contradicts scientific evidence and public opinion about the medicinal benefits of marijuana. Furthermore, it references the significant legal and financial implications that arise from maintaining such a classification, which affects both patients and dispensaries operating in New Jersey. Legalization of marijuana for recreational and medical purposes is already recognized in New Jersey, raising the need for alignment with federal laws.
AR153 argues for a significant change in federal policy regarding marijuana, which has been shown to provide relief to patients suffering from various debilitating conditions. However, there may be contention among lawmakers and constituents regarding the specifics of descheduling versus remaining on Schedule I and the implications for public health safety and crime rates associated with dispensary operations. The discussions surrounding this resolution suggest a need for a comprehensive understanding of the impact on both medical and recreational use as well as banking and business operations within the state.